News
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...
A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...
Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...
Peer-Reviewed Data Reinforces GeoVax's Multi-Antigen Strategy With GEO-CM02 and Supports Advancement of GEO-CM04S1 Clinical ...
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...
CNW/ -- (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce ...
Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results